sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo

Secreted Clusterin Gene Silencing Enhances Chemosensitivity of A549 Cells to Cisplatin Through AKT and ERK1/2 Pathwaysin Vitro

(2014) Biyuan Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Early-Stage Non-Small Cell Lung Cancer: Surgery, Stereotactic Radiosurgery, and Individualized Adjuvant Therapy

(2013) Sukhmani K. Padda et al.   SEMINARS IN ONCOLOGY

Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer

(2012) Z. Niu et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

EXPRESSION OF MULTIDRUG RESISTANCE-RELATED PROTEIN (MRP-1), LUNG RESISTANCE-RELATED PROTEIN (LRP) AND TOPOISOMERASE-II (TOPO-II) IN WILMS' TUMOR: IMMUNOHISTOCHEMICAL STUDY USING TMA METHODOLOGY

(2012) Eduard Fridman et al.   BIOMEDICAL PAPERS-OLOMOUC

Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells

(2011) Ching-Yuan Cheng et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

(2011) Janessa J. Laskin et al.   Journal of Thoracic Oncology

Advances and Challenges in Basic and Translational Research on Clusterin

(2009) I. P. Trougakos et al.   CANCER RESEARCH

Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway

(2009) Teh-Ying Chou et al.   CELLULAR SIGNALLING